Publication date: September 2026 Source: Blood Red Cells & Iron, Volume 2, Issue 3 Author(s): Yan Wang, Slim Fellah, Kristina Rankine, Martin N. Reis, Serguei Astafiev, Lauren Brewer, Morey Blinder, Allison A. King, Yasheng Chen, Sheng-Kwei Song, Hongyu An, Andria L. Ford
Brain MRI and cognitive outcomes in adults with sickle cell disease treated with crizanlizumab. // Blood Red Cells & Iron. – URL: https://www.sciencedirect.com/science/article/pii/S3050598426000545?dgcid=rss_sd_all
Brain MRI and cognitive outcomes in adults with sickle cell disease treated with crizanlizumab. Blood Red Cells & Iron. https://www.sciencedirect.com/science/article/pii/S3050598426000545?dgcid=rss_sd_all
“Brain MRI and cognitive outcomes in adults with sickle cell disease treated with crizanlizumab.” Blood Red Cells & Iron.
@article{article38957,
title = {Brain MRI and cognitive outcomes in adults with sickle cell disease treated with crizanlizumab},
journal = {Blood Red Cells \& Iron},
url = {https://www.sciencedirect.com/science/article/pii/S3050598426000545?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez